欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/0792/001
药品名称Novain 4 mg/ml Augentropfen, Lösung
活性成分
    • oxybuprocaine hydrochloride 0.4 %
剂型Eye drops, solution
上市许可持有人AGEPHA Pharma s.r.o Diaľničná cesta 5 903 01 Senec, Slovakia
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • Portugal (PT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Novain
    • Latvia (LV)
    • Denmark (DK)
    • Lithuania (LT)
      Novain 4 mg/ml akių lašai (tirpalas)
    • Netherlands (NL)
      Novain 0,4% oogdruppels, oplossing
    • Estonia (EE)
    • Iceland (IS)
    • Hungary (HU)
      Novain
    • Ireland (IE)
    • Croatia (HR)
    • Spain (ES)
许可日期2022/10/25
最近更新日期2023/04/25
药物ATC编码
    • S01HA02 oxybuprocaine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase